Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Full enrollment reached in phase II trial of CYT002-NicQb

Sep. 30, 2004

BPC-157 lessens effects of alcohol intoxication and withdrawal

Sep. 29, 2004

DOR BioPharma receives grant for ricin toxin vaccine work

Sep. 16, 2004

DigiFab submitted for approval in U.K.

Sep. 8, 2004

NRP-104 given fast track status for treating cocaine dependence

Sep. 3, 2004

Campral receives FDA approval

Aug. 3, 2004

Results of first phase III multicenter study of naltrexone depot formulation

July 22, 2004

Acamprosate does not affect alcohol pharmacokinetics and pharmacodynamics

July 21, 2004

Preliminary data on the effects and safety of TA-NIC in smokers

July 19, 2004

Combined drug therapy reduces cocaine use with limited abuse potential in primates

June 15, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...